Literature DB >> 19148714

An unusual resolution of T-wave oversensing in an implantable cardioverter defibrillator in a child with long QT syndrome.

Mitchell I Cohen1, Petros V Anagnostopoulos, Andrew Papez.   

Abstract

T-wave oversensing poses a clinical challenge often resulting in inappropriate therapies and shocks. T-wave oversensing can often be resolved by certain programmable adjustments while accepting a small risk of undersensing ventricular fibrillation. The following case depicts a girl with LQT whose transvenous defibrillator repeatedly demonstrated T-wave oversensing despite optimizing various programmable features and a separate pace/sense lead. Utilization of an LV epicardial pace/sense lead with stable R-waves affirmed an unusual resolution of T-wave oversensing and avoidance of inappropriate shocks.

Entities:  

Mesh:

Year:  2009        PMID: 19148714     DOI: 10.1007/s10840-008-9353-8

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  8 in total

1.  Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T-wave oversensing.

Authors:  T Washizuka; M Chinushi; H Kasai; H Watanabe; M Tagawa; Y Hosaka; A Abe; Y Aizawa
Journal:  Jpn Circ J       Date:  2001-07

2.  T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.

Authors:  F Roosevelt Gilliam
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

3.  Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems.

Authors:  Slawomir Weretka; Jochen Michaelsen; Ruediger Becker; Christoph A Karle; Frederik Voss; Thomas Hilbel; Brigitte R Osswald; Malte L Bahner; Julia C Senges; Wolfgang Kuebler; Wolfgang Schoels
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

4.  Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.

Authors:  Hiroshi Watanabe; Masaomi Chinushi; Daisuke Izumi; Akinori Sato; Shinsuke Okada; Kazuki Okamura; Satoru Komura; Yukio Hosaka; Hiroshi Furushima; Takashi Washizuka; Yoshifusa Aizawa
Journal:  Int Heart J       Date:  2006-05       Impact factor: 1.862

5.  Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study.

Authors:  T Korte; W Jung; G Ostermann; C Wolpert; S Spehl; B Esmailzadeh; B Lüderitz
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

6.  High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.

Authors:  Thomas Korte; Harald Köditz; Michael Niehaus; Thomas Paul; Jürgen Tebbenjohanns
Journal:  Pacing Clin Electrophysiol       Date:  2004-07       Impact factor: 1.976

7.  Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias.

Authors:  B Lüderitz; W Jung; A Deister; A Marneros; M Manz
Journal:  Pacing Clin Electrophysiol       Date:  1993-09       Impact factor: 1.976

8.  Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases.

Authors:  G Y Perry; E M Kosar
Journal:  Pacing Clin Electrophysiol       Date:  1996-05       Impact factor: 1.976

  8 in total
  1 in total

1.  T wave oversensing.

Authors:  Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.